Radiometer logo

Radiometer supports 2022 World Sepsis Congress Spotlight

PRESS RELEASE // Radiometer joins efforts with 2022 World Sepsis Congress Spotlight in the fight against sepsis

April 6, 2022

Sepsis is a very serious medical condition that presents a considerable diagnostic challenge to emergency department and intensive care clinicians.

Since 2015, Radiometer has supported Global Sepsis Alliance, a non-profit organization of more than 100 organizations with the mission to provide global leadership, increase awareness, and reduce the worldwide burden of sepsis.

This year, Radiometer is proud to support 2022 World Sepsis Congress Spotlight, hosted by Global Sepsis Alliance. 2022 World Sepsis Congress Spotlight will be held online on April 27 from 9:00 – 21:00 (CEST). The Congress—this year running on the theme “Novel Therapeutic and Diagnostic Approaches for COVID-19 and Sepsis”—brings insights from 40 international leading experts. They’ll be discussing state-of-the-art bacterial and viral sepsis knowledge, new innovative methods of diagnosis and risk assessment, cutting-edge treatment modalities, and more.

2022 World Sepsis Congress Spotlight is a global forum for healthcare authorities, non-governmental organizations, policymakers, clinical scientists, researchers, and other stakeholders. We invite you to register now to gain new insights and knowledge on sepsis.


The Congress covers 8 distinctive and highly relevant sessions:

  • Session 1 Could Enhanced Pathogen Diagnostics Change Sepsis Management?

  • Session 2 Biomarkers in the Diagnosis and Management of Sepsis and COVID-19

  • Session 3 Panel: Knowledge from COVID-19 to Improve Sepsis Care and Vice Versa

  • Session 4 How to Make the Most of Existing and Frugal Technologies

  • Session 5 Antibiotics and Antivirals – How to Improve Efficacy and to Minimize Harm

  • Session 6 Update on Adjunctive Sepsis and COVID-19 Therapies

  • Session 7 Pro-Con: Are Personalized Interventions in Sepsis Even Possible?

  • Session 8 Innovations in Quality Improvement Strategies in All Settings Join us and register now. Together, let’s raise awareness and join the fight against sepsis. 



About Radiometer

Whatever comes next, we make sure life comes first.

Radiometer develops, manufactures, and markets solutions for blood sampling, blood gas analysis, transcutaneous monitoring, immunoassay testing, and related IT management systems.  Today, Radiometer products and solutions are used in hospitals, clinics, and laboratories in over 130 countries, providing information on critical parameters in acute care diagnostics. 

Through connected solutions, expert knowledge, and trusted partnership, we help health care professionals make diagnostic decisions to improve patient care.

Cookies are used on this website

Use of cookies
Confirm your account with Radiometer

Please enter a valid email

By submitting your e-mail you agree to the data policy notice
Radiometer is using Microsoft Azure Active Directory to authenticate customer access. If you are already registered you will be taken to Microsoft AD to sign in using your Microsoft AD credentials.
You are already registered
Radiometer is using Microsoft Azure AD to authenticate customer access. If you are already registered you will be taken to AZURE to sign in using your AZURE credentials.
Thank you

We will be sending an e-mail invitation to you shortly to sign in using Microsoft Azure AD.

Radiometer is using Microsoft Azure AD to authenticate customer access.

It seems that your e-mail is not registered with us

Radiometer is using Microsoft Azure AD to authenticate customer access. If your e-mail is not registered with us please click CONTINUE and we will guide you through the sign-in process.
We have previously sent an invitation by e-mail

Please click "Get started" in the e-mail to complete the registration process

Radiometer is using Microsoft Azure AD to authenticate customer access.

We were not able to process your request due to a communication error


It seems this account has not been given access to the portal

Radiometer is using Microsoft AZURE Active Directory to authenticate users

Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.

If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.

Key benefits

  • Allow the use of existing Active Directory credentials
  • Single-sign on experience
  • Use same credentials to access future services

Request access

You will receive an invitation to access our services via e-mail when your request has been approved.

When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.

Effective Date January 20th, 2023 (last updated January 20th, 2023)


Radiometer values your privacy and the protection of your personal data. This policy (“Policy”) explains how Radiometer its affiliates, subsidiaries or related companies, a full list of which can be located here (together, “Radiometer”, “our”, “us”, or “we”), collects, uses, shares, transfers and processes data collected from or about you.

Personal Data” is any information that can be used to directly or indirectly identify an individual or that can be reasonably expected to link to an individual. This can include items such as name, address, telephone number, credit card details, email address, ID number, Internet Protocol (“IP”) address of an electronic device used by an individual, or other identifying code (even absent of other identifying information). Statistical and non-identifiable metric data are not considered Personal Data.

The Radiometer subsidiary, affiliate or related company with which you interact is, where applicable, the data controller (or equivalent under applicable law) responsible for the processing of your Personal Data. You can find a list of the relevant legal entities that act as data controllers in Appendix 1 to this Policy.


This Policy describes the types of Personal Data that we may collect, process or disclose about you and how you may govern this processing by exercising applicable legal rights. This Policy applies to both online and offline information collection, including your use of websites or subdomains operated by us, any mobile applications, when we provide products and/or services to you or notify you about prospective items of interest and in other situations where you interact with us in-person, by telephone or by mail where this Policy is posted or referenced.

There may be occasion where you have been provided with a circumstance-specific privacy notice that is separate from this policy, such as privacy notices for specific activities such as Recruitment. To the extent you were provided with a different notice, those notices apply and govern our interactions with you. If you provide Personal Data about parties other than yourself, you are responsible for ensuring their knowledge of how we will process their personal data, and, where applicable, obtaining any necessary consents required in advance.

We are committed to processing Personal Data in accordance with applicable laws. Please note that if you do not wish to provide your Personal Data to us, some products and/or services may become unavailable to you. Your use of any or all these platforms indicates you have been notified of our collection, use, transfer, and disclosure of your information as described in this Policy to the extent permitted by applicable law.

Read more